Latest Period
n/a
Security Snapshot
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) Institutional Ownership
CUSIP: 87184Q107
13F Institutional Holders and Ownership History from Q2 2016 to Q2 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- SYRS on Nasdaq
- Shares outstanding
- 27,995,500
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 87184Q107.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q1 2023 and Q2 2023.
- SEC-reported value moved from $585 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
87184Q107
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
SYRS full holder history
Syros Pharmaceuticals, Inc. SEC filings
Syros Pharmaceuticals, Inc. company facts
Syros Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87184Q107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
SYRS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 3.8% | $776,595 | 1,063,829 | Invus Public Equities, L.P. | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
n/a
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$585 | 0 | |
| 2023 Q1 | 219 | $585 | $2.67 | 1 | |
| 2022 Q4 | 219 | $786 | -$5,677,000 | $3.59 | 1 |
| 2022 Q3 | 881,719 | $5,679,000 | -$38,920,523 | $6.44 | 3 |
| 2022 Q2 | 35,563,928 | $34,226,317 | -$9,550,880 | $0.96 | 58 |
| 2022 Q1 | 44,600,309 | $53,054,739 | -$16,229,688 | $1.19 | 86 |
| 2021 Q4 | 51,167,771 | $165,935,422 | +$2,424,541 | $3.26 | 84 |
| 2021 Q3 | 47,185,070 | $209,928,186 | -$4,801,116 | $4.47 | 92 |
| 2021 Q2 | 47,939,973 | $259,937,712 | -$108,395,908 | $5.45 | 95 |
| 2021 Q1 | 60,879,549 | $453,765,087 | +$51,303,227 | $7.48 | 99 |
| 2020 Q4 | 53,645,472 | $580,176,544 | +$89,474,242 | $10.85 | 99 |
| 2020 Q3 | 46,027,616 | $405,893,308 | +$16,189,114 | $8.84 | 91 |
| 2020 Q2 | 39,975,459 | $425,248,905 | +$6,981,050 | $10.66 | 77 |
| 2020 Q1 | 44,878,307 | $265,481,374 | +$15,181,069 | $5.93 | 63 |
| 2019 Q4 | 42,159,417 | $290,644,730 | -$8,983,413 | $6.91 | 70 |
| 2019 Q3 | 43,076,602 | $446,224,216 | +$88,973,322 | $10.38 | 61 |
| 2019 Q2 | 31,644,913 | $291,721,875 | +$102,579,332 | $9.26 | 66 |
| 2019 Q1 | 20,623,242 | $188,494,058 | +$16,131,561 | $9.14 | 63 |
| 2018 Q4 | 22,234,612 | $123,844,000 | +$995,029 | $5.57 | 67 |
| 2018 Q3 | 17,416,778 | $207,439,026 | +$2,479,368 | $11.91 | 73 |
| 2018 Q2 | 17,226,749 | $175,885,142 | +$16,540,742 | $10.21 | 73 |
| 2018 Q1 | 18,506,513 | $240,212,598 | +$38,686,687 | $12.98 | 54 |
| 2017 Q4 | 15,877,766 | $154,493,194 | +$4,671,125 | $9.73 | 68 |
| 2017 Q3 | 12,031,237 | $177,159,772 | +$16,405,535 | $14.72 | 66 |
| 2017 Q2 | 10,799,619 | $173,764,545 | +$43,612,075 | $16.09 | 45 |